Schwab U.S. Mid-Cap ETF (NYSEARCA:SCHM) Sees Significant Growth in Short Interest

Chronological Source Flow
Back

AI Fusion Summary

Schwab U.S. Mid-Cap ETF’s short interest rose 40.8% to 653,299 shares by March 31, 0.2% shorted, 0.5 days-to-cover. Allogene Therapeutics’ short interest grew 31.3% to 32,060,091 shares, 15.2% shorted, 4.8 days ratio, trading up 9.2% at $2.37.
#SCHWAB_US_MID_CAP_ETF #ALLOGENE_THERAPEUTICS #SHORT_INTEREST #MARCH_2024 #ETF #STOCK #FINANCE
17/04 08:17 defenseworld.net
3 Πηγές

Schwab U.S. Mid-Cap ETF (NYSEARCA:SCHM) Sees Significant Growth in Short Interest

COMPANIESOPTIONS ARTICLESPOLITICS
17/04 10:48 defenseworld.net

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Sees Significant Growth in Short Interest

COMPANIESOPTIONS ARTICLESPOLITICS
17/04 11:18 defenseworld.net

Aeluma, Inc. (NASDAQ:ALMU) Sees Significant Increase in Short Interest

COMPANIESOPTIONS ARTICLESPOLITICS
Comments
Loading...
0